Capecitabine

Capecitabine can harm the unborn baby and should not be used during pregnancy . Women who could become pregnant should use effective contraception during treatment and for the period advised by their doctor after treatment.

No. Breastfeeding is not recommended during treatment with capecitabine because it may pass into breast milk and could cause serious side effects in the nursing infant.

The medicine may affect driving ability in some patients. Dizziness, weakness, tiredness, visual disturbances or other nervous-system effects can occur. If you experience these symptoms after taking Capecitabine, inform your doctor and avoid driving or operating machinery until you feel well enough to do so safely.

There is no specific established alcohol interaction with Capecitabine . However, alcohol may worsen symptoms such as tiredness, dizziness, or stomach upset. Discuss alcohol consumption with your doctor.

Your doctor may delay treatment, reduce the dose or temporarily stop treatment until your blood counts recover. Both capecitabine and cyclophosphamide can suppress bone marrow, so blood tests are an important part of monitoring, and you should attend all the tests scheduled by your doctor.

Warfarin requires particular caution because capecitabine can increase its blood-thinning effect and cause serious bleeding. More frequent INR monitoring and possible dose adjustment may be necessary as recommended by your doctor.

Capecitabine can cause hand-and-foot syndrome. It may begin with redness, tingling or sensitivity and can progress to painful swelling, peeling or skin damage. Report worsening symptoms early because treatment interruption or dose modification may be required based on your individual situation.